QNRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Quoin Pharmaceuticals Ltd (QNRX) is not a strong buy for a beginner, long-term investor at this time. The technical indicators show mixed signals, with bearish moving averages and neutral RSI. The company has weak financial performance with negative net income and EPS, and no significant positive catalysts or trading signals to support a buy decision. Given the lack of strong growth trends or positive sentiment, it's best to hold off on investing in this stock for now.
The MACD histogram is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 55.507, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 8.244), which may limit further upside in the short term.
The MACD is showing bullish momentum, and the stock has an 80% chance of gaining 6.6% in the next month based on candlestick pattern analysis.
The moving averages are bearish, and the RSI is neutral, showing no strong upward momentum. The company's financials are weak, with negative net income and EPS. There is no recent news or significant insider/hedge fund trading activity to drive positive sentiment.
In Q3 2025, the company's revenue remained at 0 with no growth. Net income improved by 68.02% YoY but remains negative at -$3,948,165. EPS dropped significantly by -58.81% YoY to -6.71, indicating worsening profitability.
No analyst rating or price target data available.
